Professional Summary

Professional Overview

Greg Flexter is an accomplished pharmaceutical executive with over 40 years of industry experience. As the President, CEO, and Co-Founder of Blue Ash Therapeutics, he leverages his extensive expertise in drug development, marketing, and business strategy to drive the company's success in the rapidly evolving healthcare landscape.

Experience Summary

Current Role

Since co-founding Blue Ash Therapeutics in 2009, Greg has served as the President, CEO, and a member of the Board of Directors. In this role, he is responsible for setting the strategic vision, overseeing all business operations, and fostering a culture of innovation and collaboration. Under his leadership, Blue Ash Therapeutics has emerged as a leading player in the development of novel therapeutic solutions, with a growing pipeline of promising drug candidates.

Career Progression

Prior to his current role, Greg held several high-level executive positions within the pharmaceutical industry. He served as the President, CEO, and Board Member at Xanodyne Pharmaceuticals, where he spearheaded the company's strategic initiatives and operational excellence. Before that, he was the Executive Vice President and General Manager of the North America division at Shire Pharmaceuticals, where he played a pivotal role in driving the company's growth and market expansion. Earlier in his career, Greg held senior-level positions at Novartis and Hoechst Marion Roussel, where he demonstrated his expertise in global marketing, medical research, and product development.

Academic Background

Greg holds a Bachelor's degree in Pharmaceutical Sciences from the University of Cincinnati, where he graduated with distinction.

Areas of Expertise

Greg's areas of expertise include pharmaceutical product development, global marketing and commercialization, strategic business planning, and organizational leadership. He has a proven track record of successfully navigating complex regulatory environments, fostering collaborative partnerships, and driving innovation to address unmet medical needs.

Professional Impact

Throughout his illustrious career, Greg has made significant contributions to the pharmaceutical industry. He has been instrumental in the development and commercialization of several groundbreaking therapies, which have improved the quality of life for countless patients worldwide. Additionally, Greg has actively participated in industry associations and advisory boards, sharing his insights and advocating for policies that foster continued advancements in healthcare.

Conclusion

Greg Flexter's extensive experience, strong leadership skills, and deep industry knowledge position him as a highly respected and influential figure in the pharmaceutical sector. As the President, CEO, and Co-Founder of Blue Ash Therapeutics, he continues to drive innovation, build strategic partnerships, and deliver sustainable value for the company, its stakeholders, and the patients it serves.